Direct-to-patient BRCA1 testing: The Twoj Styl experience

Breast Cancer Research and Treatment

Volumn 100, Issue 3, 2006, Pages 239-245

  Gronwald, Jacek ^a   Huzarski, Tomasz ^a   Byrski, Tomasz ^a   Dębniak, Tadeusz ^a   Metcalfe, Kelly ^b,c   Narod, Steven A ^c   Lubiński, Jan ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

BRCA1; Breast cancer; Genetic counseling; Ovarian cancer

Indexed keywords

BRCA1 PROTEIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER SCREENING; CONTROLLED STUDY; COST; FAMILY HISTORY; FEMALE; FOUNDER EFFECT; GENE MUTATION; GENETIC COUNSELING; GENETIC SCREENING; HEALTH PROGRAM; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; NORTH AMERICA; OVARY CANCER; PATIENT SATISFACTION; POLAND; PRIORITY JOURNAL; UNITED STATES;

EID: 33750725699     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-006-9261-5     Document Type: Article

References (16)

1. Schwartz LM, Woloshin S (2002) News media coverage of screening mammography for women in their 40s and tamoxifen for primary prevention of breast cancer. JAMA 287(23):3136-3142
2. Lodder L, Frets PG, Trijsburg RW, et al (2001) Psychological impact of receiving a BRCA1/BRCA2 test result. Am J Med Genet 98(1):15-24
3. Hopwood P, Shenton A, Lalloo F, Evans DG, Howell A (2001) Risk perception and cancer worry: an exploratory study of the impact of genetic risk counselling in women with a family history of breast cancer. J Med Genet 38(2):139
4. Watson M, Duvivier V, Wade Walsh M, et al (1998) Family history of breast cancer: what do women understand and recall about their genetic risk? J Med Genet 35(9):731-738
5. Black WC, Nease RF, Tosteson AN (1995) Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age. J Natl Cancer Inst 87(10):720-731
6. Dolan NC, Lee AM, McDermott MM (1997) Age-related differences in breast carcinoma knowledge, beliefs, and perceived risk among women visiting an academic general medicine practice. Cancer 80(3):413-420
7. Hebert-Croteau N, Goggin P, Kishchuk N (1997) Estimation of breast cancer risk by women aged 40 and over: a population-based study. Can J Public Health 88(6):392-396
8. Metcalfe KA, Liede A, Hoodfar E, Scott A, Foulkes WD, Narod SA (2000) An evaluation of needs of female BRCA1 and BRCA2 carriers undergoing genetic counselling. J Med Genet 37:866-874
9. Menkiszak J, Rzepka-Gorska I, Gorski B, et al (2004) Attitudes toward preventive oophorectomy among BRCA1 mutation carriers in Poland. Eur J Gynaecol Oncol 25(1):93-95
10. Gorski B, Jakubowska A, Huzarski T, et al (2004) A high proportion of founder BRCA1 mutations in Polish breast cancer families. Int J Cancer 110(5):683-686
11. Liede A, Metcalfe K, Hanna D, et al (2000) Evaluation of the needs of male carriers of mutations in either BRCA1 or BRCA2 who are undergoing genetic counseling. Am J Human Genet 67:1494-1504
12. Metcalfe KA, Liede A, Trinkaus M, Hanna D, Narod SA (2002) Evaluation of the needs of spouses of female carriers of mutations in BRCA1 and BRCA2. Clin Genet 62:464-469
13. Lerman C, Narod S, Schulman K, et al (1996) BRCA1 testing in families with hereditary breast-ovarian cancer: a prospective study of patient decision making and outcomes. JAMA 275(24):1885-1892
14. Metcalfe KA, Esplen MJ, Goel V, Narod S (2004) Psychosocial functioning in women who have undergone bilateral prophylactic mastectomy. Psychooncology 13:14-25
15. Lubinski J, Gorski B, Huzarski T, et al (2006) BRCA1-positive breast cancers in young women from Poland. Breast Cancer Res Treat Mar 16; [Epub ahead of print]
16. Mouchawar J, Hensley-Alford S, Laurion S, et al (2005) Impact of direct-to-consumer advertising for hereditary breast cancer testing on genetic services at a managed care organization: a naturally-occurring experiment. Genet Med 7(3):191-197